— Know what they know.
Not Investment Advice
Also trades as: 0I1B.L (LSE) · $vol 0M

ENOV NYSE

Enovis Corporation
1W: -5.8% 1M: +3.5% 3M: +8.2% YTD: -7.2% 1Y: -28.6% 3Y: -56.7% 5Y: -67.5%
$24.19
-0.40 (-1.63%)
 
Weekly Expected Move ±10.8%
$19 $22 $24 $27 $30
NYSE · Healthcare · Medical - Devices · Alpha Radar Neutral · Power 54 · $1.4B mcap · 57M float · 1.81% daily turnover · Short 63% of daily vol

Cash Flow Trends

Operating Cash Flow
$217M +91.4% ▲
5Y CAGR: -6.4%
Capital Expenditures
$197M -9.2% ▼
5Y CAGR: +11.5%
Free Cash Flow
$20M +129.6% ▲
5Y CAGR: -36.1%
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +100.0% ▲
Net Change in Cash
-$12M -453.2% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income$76M-$12M-$33M-$825M-$1.2B
Depreciation & Amort.$263M$220M$217M$285M$294M
Stock-Based Comp.$35M$39M$34M$30M$33M
Change in Working Capital-$17M-$220M-$27M-$14M$15M
Other Non-Cash Items$21M-$89M-$28M$648M$1.1B
Operating Cash Flow$356M-$56M$135M$114M$217M
— Investing Activities —
Capital Expenditures-$104M-$105M-$122M-$181M-$197M
Acquisitions (Net)-$223M-$74M-$153M-$770M$16M
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing$7M$3M$33M-$5M$2M
Investing Cash Flow-$320M-$176M-$242M-$955M-$179M
— Financing Activities —
Net Debt Issuance-$150M-$1.6B$217M$859M-$44M
Stock Repurchased$0$0$0-$5M$0
Dividends Paid$0$0$0$0$0
Other Financing-$10M$1.1B-$91M-$10M-$10M
Financing Cash Flow$585M-$465M$128M$847M-$52M
Net Change in Cash$618M-$695M$21M$3M-$12M
Cash End of Period$719M$24M$45M$48M$36M
Free Cash Flow$252M-$161M$13M-$67M$20M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms